2025 annual financial data
Evommune 2025 Operating margin
Evommune 2025 operating margin with verified reported values.
Direct answer
Operating margin was -623.62%.
Operating income was -81,071,000 USD and net income was -68,870,000 USD.
Operating cash flow was -76,441,000 USD.
Get free Evommune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 13,000,000 USD
- Operating income
- -81,071,000 USD
- Net income
- -68,870,000 USD
- Operating cash flow
- -76,441,000 USD